Lin Bao

1.4k total citations
29 papers, 875 citations indexed

About

Lin Bao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lin Bao has authored 29 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Lin Bao's work include Renal cell carcinoma treatment (11 papers), Ferroptosis and cancer prognosis (8 papers) and Renal and related cancers (7 papers). Lin Bao is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Ferroptosis and cancer prognosis (8 papers) and Renal and related cancers (7 papers). Lin Bao collaborates with scholars based in China and France. Lin Bao's co-authors include Hailong Ruan, Xiaoping Zhang, Hongmei Yang, Ke Chen, Zhengshuai Song, Tianbo Xu, Haibing Xiao, Di Liu, Qi Cao and Keshan Wang and has published in prestigious journals such as Oncogene, Clinical Cancer Research and Experimental Cell Research.

In The Last Decade

Lin Bao

28 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Bao China 18 620 453 355 147 83 29 875
Tianbo Xu China 19 512 0.8× 305 0.7× 324 0.9× 112 0.8× 70 0.8× 27 728
Simeng Wen China 17 559 0.9× 407 0.9× 310 0.9× 224 1.5× 73 0.9× 30 933
Kathryn Bieging-Rolett United States 7 638 1.0× 485 1.1× 400 1.1× 196 1.3× 43 0.5× 11 859
Ting Hong China 8 424 0.7× 350 0.8× 347 1.0× 115 0.8× 33 0.4× 14 650
Yifeng Tian China 16 479 0.8× 413 0.9× 102 0.3× 203 1.4× 61 0.7× 37 775
Rebecca Deasy United States 2 482 0.8× 414 0.9× 523 1.5× 101 0.7× 65 0.8× 3 737
Maria Quiles del Rey United States 7 373 0.6× 341 0.8× 151 0.4× 108 0.7× 40 0.5× 8 625
Zhi-Ming Shao China 7 464 0.7× 365 0.8× 222 0.6× 360 2.4× 151 1.8× 10 862
Yan‐Xing Chen China 14 391 0.6× 318 0.7× 164 0.5× 261 1.8× 149 1.8× 23 739
Emily K. Kleczko United States 14 435 0.7× 143 0.3× 249 0.7× 249 1.7× 152 1.8× 22 746

Countries citing papers authored by Lin Bao

Since Specialization
Citations

This map shows the geographic impact of Lin Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Bao more than expected).

Fields of papers citing papers by Lin Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Bao. The network helps show where Lin Bao may publish in the future.

Co-authorship network of co-authors of Lin Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Bao. A scholar is included among the top collaborators of Lin Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Bao. Lin Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Mengyu, Jincheng Guo, Haodong Yao, et al.. (2025). Adjuvant-metal-ion-chelating PTEN mRNA with cell-membrane-coating augments the immune sensitivity for precise cancer immunotherapy. Science Bulletin. 71(3). 609–622.
2.
Tian, Wenyi, Yuling Li, Fengzhi Liu, et al.. (2025). Strychni Semen and two alkaloidal components cause apoptosis in HK-2 cells through TRADD-MAPK/NF-κB pathway. Toxicon. 256. 108224–108224. 1 indexed citations
3.
Ruan, Hailong, Lin Bao, Zhen Tao, & Ke Chen. (2021). Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer. Cancer Immunology Research. 9(7). 838–852. 22 indexed citations
4.
Ruan, Hailong, Sen Li, Lin Bao, & Xiaoping Zhang. (2020). Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. Oncogene. 39(38). 6113–6128. 32 indexed citations
5.
Ruan, Hailong, Zhengshuai Song, Qi Cao, et al.. (2020). IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors. Molecular Therapy. 28(5). 1299–1313. 20 indexed citations
6.
Hu, Junyi, Zhaohui Chen, Lin Bao, et al.. (2020). Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes. Molecular Therapy. 28(7). 1658–1672. 121 indexed citations
7.
Bao, Lin, Chenchen Liu, Qi Cao, et al.. (2020). The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma. Journal of Cancer. 11(7). 1712–1726. 6 indexed citations
8.
Liu, Yuenan, Gong Cheng, Ziwei Huang, et al.. (2020). Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Cell Death and Disease. 11(7). 515–515. 90 indexed citations
9.
Cao, Qi, Zhengshuai Song, Hailong Ruan, et al.. (2019). Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer. Clinical Cancer Research. 26(6). 1516–1528. 45 indexed citations
10.
Wang, Keshan, Tianbo Xu, Hailong Ruan, et al.. (2019). LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma. Cell Death and Disease. 10(3). 159–159. 31 indexed citations
11.
Ruan, Hailong, Sen Li, Junwei Tong, et al.. (2019). The screening of pivotal gene expression signatures and biomarkers in renal carcinoma. Journal of Cancer. 10(25). 6384–6394. 6 indexed citations
12.
Liu, Yuenan, Gong Cheng, Zhengshuai Song, et al.. (2019). RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma. International Journal of Oncology. 55(3). 645–656. 25 indexed citations
13.
Xu, Tianbo, Hailong Ruan, Zhengshuai Song, et al.. (2019). Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Biomedicine & Pharmacotherapy. 118. 109264–109264. 26 indexed citations
14.
Song, Zhengshuai, Qi Cao, Hailong Ruan, et al.. (2018). RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma. Experimental Cell Research. 372(2). 118–128. 18 indexed citations
15.
Wang, Keshan, Hailong Ruan, Zhengshuai Song, et al.. (2018). PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(7). 343.e9–343.e19. 36 indexed citations
16.
Xu, Guang‐Hua, Ning Lou, Hangchuan Shi, et al.. (2018). Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. BMC Cancer. 18(1). 88–88. 45 indexed citations
17.
Cao, Qi, Hailong Ruan, Keshan Wang, et al.. (2018). Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. International Journal of Oncology. 53(1). 137–147. 64 indexed citations
18.
Qü, Yan, Haibing Xiao, Zhiyong Xiong, et al.. (2018). Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma. Cellular Physiology and Biochemistry. 48(3). 1075–1087. 49 indexed citations
19.
Xiao, Wen, Ning Lou, Hailong Ruan, et al.. (2017). Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A. Cellular Physiology and Biochemistry. 43(6). 2420–2433. 79 indexed citations
20.
Lou, Ning, Anming Ruan, Bin Qiu, et al.. (2016). miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(1). 36.e7–36.e14. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianbo Xu Breakdown of academic impact, for papers by Simeng Wen Breakdown of academic impact, for papers by Kathryn Bieging-Rolett Breakdown of academic impact, for papers by Ting Hong Breakdown of academic impact, for papers by Yifeng Tian Breakdown of academic impact, for papers by Rebecca Deasy Breakdown of academic impact, for papers by Maria Quiles del Rey Breakdown of academic impact, for papers by Zhi-Ming Shao Breakdown of academic impact, for papers by Yan‐Xing Chen Breakdown of academic impact, for papers by Emily K. Kleczko
Rankless by CCL
2026